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Abstract
Human infection by simian foamy viruses (SFV) can be acquired by persons occupationally exposed to non-human primates
(NHP) or in natural settings. This study aimed at getting better knowledge on SFV transmission dynamics, risk factors for
such a zoonotic infection and, searching for intra-familial dissemination and the level of peripheral blood (pro)viral loads in
infected individuals. We studied 1,321 people from the general adult population (mean age 49 yrs, 640 women and 681
men) and 198 individuals, mostly men, all of whom had encountered a NHP with a resulting bite or scratch. All of these,
either Pygmies (436) or Bantus (1085) live in villages in South Cameroon. A specific SFV Western blot was used and two
nested PCRs (polymerase, and LTR) were done on all the positive/borderline samples by serology. In the general population,
2/1,321 (0.2%) persons were found to be infected. In the second group, 37/198 (18.6%) persons were SFV positive. They
were mostly infected by apes (37/39) FV (mainly gorilla). Infection by monkey FV was less frequent (2/39). The viral origin of
the amplified sequences matched with the history reported by the hunters, most of which (83%) are aged 20 to 40 years
and acquired the infection during the last twenty years. The (pro)viral load in 33 individuals infected by a gorilla FV was
quite low (,1 to 145 copies per 10
5 cells) in the peripheral blood leucocytes. Of the 30 wives and 12 children from families
of FV infected persons, only one woman was seropositive in WB without subsequent viral DNA amplification. We
demonstrate a high level of recent transmission of SFVs to humans in natural settings specifically following severe gorilla
bites during hunting activities. The virus was found to persist over several years, with low SFV loads in infected persons.
Secondary transmission remains an open question.
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Introduction
Most of the viral pathogens that have emerged in humans
during the last decades have originated from various animals,
either domestic or living in the wild [1,2,3,4]. After the initial
interspecies transmission, these viruses have followed different
evolutionary routes and spread into the human population
through various distinct mechanisms. Such mechanisms have
been well studied, often well understood, thus allowing a certain
level of risk control, and a decrease of inter-human dissemination
[3,4,5]. In contrast, the understanding of the initial steps of the
emergence of several viruses and associated diseases often remains
quite poor. Epidemiological and microbiological studies in specific
high-risk groups and populations are thus necessary to gain new
insights into the early events of the emergence process.
Nonhuman primates (NHPs) are hosts for several pathogens
potentially transmissible to humans. Indeed, people in contact with
NHPs are at risk for infection with viruses such as Simian T
Lymphotropic Viruses [6,7,8,9,10,11,12] or Simian Immunodefi-
ciency Viruses through interspecies transmission [13,14,15,16,17].
Simian foamy viruses are exogenous complex retroviruses of the
Spumaretrovirinae subfamily [18,19]. They are highly prevalent in
several animal species, in which they cause persistent infection
[20,21,22,23]. Switzer et al., suggested that foamy viruses have co-
speciated with Old World NHPs for at least 30 million years [24].
Such a long-term co-evolution may explain their apparent lack of
pathogenicity observed in vivo, and the persistence of the infection.
Indeed, SFVs are considered to be non pathogenic in naturally or
experimentally infected animals, even though disease association
has not been systematically evaluated in any NHPs species. This
strongly contrasts with the in vitro cytopathic effect seen in infected
cell cultures, with a characteristic foamy appearance of vacuolized
cells [25].
SFV seroprevalence in captive adult NHP populations can
reach 75–100% [26,27,28,29,30]. The situation seems very similar
in semi-free ranging colonies [31,32] and in wild troops
[33,34,35]. Transmission of SFV among NHPs occurs via infected
body fluids, mainly through biting, but also with grooming and
possibly to a lesser extent, sexual contacts [32,34]. SFV appears to
be present at high concentration in the saliva of infected animals
[36,37,38] and viral replication has been shown to occur in a
superficial cell niche of the oral mucosa in macaques [38].
The first FV to be isolated in humans was reported by Achong
in 1971 [39]. This virus was identified in a cell culture from a
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Further phylogenetic analysis indicated that this virus was from
an east African Chimpanzee subspecies and the virus was now
renamed ‘‘the prototype HFV’’ [40]. However, the first clear
evidence of SFV in humans was demonstrated in 1995 by
Schweizer et al., who found antibodies directed against SFV
antigens and the presence of FV DNA in the peripheral blood of 3
persons among 41 laboratory and animal house personnel [27].
These initial studies were followed by series of others, mainly by
a CDC team led by Dr W. Heneine and W. Switzer who
published a series of clear demonstrations of the presence of SFV
infection in cohorts of workers occupationally exposed to NHP,
including animal caretakers, research scientists, and veterinarians
[41,42,43,44]. In most cases, the supposed infecting contacts were
bites, from chimpanzees and African monkeys and, to a lesser
extent, puncture wounds. In rare cases, no evident risk factors
were identified, suggesting that other cutaneomucous contacts can
also lead to such zoonotic infection [44,45]. The next step was to
search for such zoonotic infection in a more natural setting. Wolfe
el al. pioneered the work by investigating the presence of SFV in
villagers of South Cameroon reporting direct contacts with blood
and/or body fluid from wild NHPs. This study demonstrated the
presence of antibodies directed against SFV in 1% of the 1099
tested individuals and the presence of SFV sequences in the blood
of 3 persons [46]. Our team has developed and extended such
results in South Cameroon, demonstrating the presence of
persistent SFV infection in a series of 13 individuals all, except
one, being men bitten during hunting activities in the forest, by an
ape or a monkey [47]. Studies in South-east Asia showed
transmission of macaque SFVs in a series of 10 people including
zoo workers, owner of NHP pets, bush meat-hunters and temple
workers [33,48]. Furthermore, mathematical modeling showed
that in Bali, about six of every 1000 visitors to monkey temples will
be infected by SFV [49].
In an area of high NHP diversity and ongoing ecologic and
socio-demographic changes, the goals of the present study were to
gain new insights into the risk factors associated with the presence
of SFV infection in human populations neighboring a nature
reserve rich in game. In this area, hunting and butchering for
subsistence are still very active. A second goal was to characterize
SFV strains and viral loads in peripheral blood of infected
individuals and finally, we searched for any intra-familial
dissemination of SFV from the originally infected index cases.
Materials and Methods
Clearance and ethics
The study received administrative and ethical clearance
in Cameroon from the research division of the Ministry of
PublicHealth(referenceD30-295/AR/MINSANTE/SG/DROS/
CRC/CEA1) and from the National Comity of Ethics (reference
034//CNE/MP/06), and in France, from the ‘‘Comite ´d e
Protection des Personnes’’ (reference 2011/01NICB) and the
‘‘Commission Nationale de l’Informatique et des Liberte ´s’’
(reference EGY/FLR/AR111711). Prior to field sampling, com-
munity and individual written informed consent was provided by
participants after detailed information and explanations of the study
were provided. Written consent for children underage was obtained
from their parents or recognized guardians.
The population
This study was carried out in rural areas located in south and
east Cameroon (figure 1) in a rainforest region home to a variety of
non human primate (NHP) species. The human populations in
these areas include numerous Bantu tribes including. Pygmies in
this work are from the Baka and the Bakola tribes [50]. A large
part of this study was focused on areas and villages surrounding
and within the Dja and Campo Maan nature reserves (figure 1). A
systematic approach for the enrolment of adults was carried out in
the populations (Pygmies and Bantus) in all reachable villages and
settlements, scattered alongside roads and tracks across the forest.
A standardized questionnaire was used to collect personal
epidemiological data and two study population groups were
defined. A large group designated ‘‘general population’’, included
all consenting subjects who had been living in the study areas for
several years and been exposed to NHPs. A second group, smaller
in size, designated the ‘‘contact group’’, made up of all those
individuals who had reported an encounter with a NHP during
their lifetime, and which has resulted in physical injury by a
scratch, a bite or both, from the animal in question. The
classification into the two groups was made on the basis of a simple
questionnaire, and an explicit declaration of an injury related to
contact with a NHP, no matter what the circumstances. Collected
data included the name, age, sex, location, ethnicity and family
links, as well as specific questions about date of contacts with
NHPs, the location, description of circumstances, the type and site
of body lesions if any and the presence of after-effects.
A 5 to 10 ml whole blood sample was collected in EDTA K2
vacuum tubes, from all consenting individuals meeting the
inclusion criteria. Plasma and buffy-coat were obtained 48 to
72 hours after sampling and kept frozen at 280uC.
A simple clinical examination was performed when requested
by participants in the study. Treatment for common local ailments
was given if available. A transfer to an appropriate medical facility
was advised for severely ill individuals encountered on site.
Serologic tests
All available plasma was screened with an experimental WB
method, using a classical antigen produced in baby hamster kidney
cells (BHK-21), infected by the prototype strain HFV [39] at a
MOI (Multiplicity of infection)=1. All samples were screened with
Author Summary
Most of the viral pathogens that have emerged in humans
during the last decades have a zoonotic origin. After the
initial interspecies transmission, these viruses have fol-
lowed different evolutionary routes and have spread
among humans through distinct mechanisms. The under-
standing of the initial steps of the emergence of several
viruses and associated diseases often remains quite poor.
Human infection by simian foamy viruses (SFV) can be
acquired by persons occupationally exposed to non-
human primates (NHP) or in natural settings. Epidemio-
logical and microbiological studies in specific high-risk
populations are necessary to gain new insights into the
early events of the emergence process, and the potential
to spread or cause disease among humans. The present
study found that hunting is still a very common and risky
activity for SFV infection in forest areas of South
Cameroon. Indeed, recent interspecies transmission of
SFVs to young adults is still very frequent, as 1 person out
of 5 among the hunters who have reported a bite or
scratch by a non-human primate and 2 persons out of a
thousand in the general population are persistently
infected by a SFV, mostly from an ape. Secondary
transmission to other family members and presence of a
disease in infected persons are still open questions that are
being investigated.
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were tested anew with a concentrated purified antigen obtained
from a culture supernatant, for clearer and more conclusive
results. This antigen was produced from a cell lysate, filtrated
through a 0.45 mm filter followed by 40 minutes of ultracentrifu-
gation at 25000 rpm. The resulting concentrated pellet was
suspended in 16 Laemmli buffer and kept frozen at 220uC.
Antigenic 70 kDa and 74 kDa Gag proteins were separated by a
4 hour migration on polyacrylamide 10% bis tris gel (INVITRO-
GEN, Aukland, New Zealand) with a direct 130 V filed. Antigens
were transferred to a polyvinylidene fluoride (PVDF) membrane.
Positivity in serology was considered as the presence of the p70
and p74 Gag doublet (figure 2-A). Samples showing only one of
the two Gag proteins were considered indeterminate and absence
of doublet was considered a negative result.
Molecular studies
High molecular weight genomic DNA was extracted from the
buffy-coat of all individuals whose plasma was WB positive or
indeterminate for the Gag doublet with a blood extraction kit
(Qiagen, Gmbh, Hilden Germany) and for all subjects in the
‘‘contact group’’, independently of their WB result. Quantified
DNA (Biophotometer RS 232 C; Eppendorf, Hamburg, Germany)
was amplified (Mastercycler, epGradient; Eppendorf) for a 229 bp
fragment of the b-globin gene with primers PCO4 and GH2O as
previously described [51]. Two nested PCRs were carried out for
the specific detection of SFV DNA. Amplification of a 465 bp
fragment on the pol-In (polymerase gene-Integrase), was done for 35
cycles (300 denaturation at 95uC, 300 annealing at 55uC, 19
extension at 72uC and final 79 extension step at 72uC) using highly
generic primers (POL1outse, POL2outas,POL3inse, POL4inas) as
previously described [52]. The second PCR was hemi-nested and
amplified a fragment of the LTR for 35 cycles (300 denaturation at
95uC, 300 annealing at 55uC, 300 extension at 72uC and final 79
extension step at 72uC), using generic primers (PBF1se, PBF2as
and PBF3se) [53]. ‘‘Classical’’ criteria for SFV infection were
defined as 1) clear positivity to WB and 2) positive PCR for the pol-
In and/or the LTR DNA fragments. The few individuals with a
positive PCR and a negative or indeterminate WB were defined as
‘‘non classical’’. Amplified DNA was purified with a gel extraction
kit (Qiagen, Gmbh, Hilden Germany), and inserted into a 3.9
pCR 2.1 plasmid vector (Invitrogen) with the Rapid DNA ligation
kit (ROCHE). Plasmids were cloned in chemically competent
Escherischia coli (Invitrogen). Two to four different bacterial
clones were selected for plasmid extraction and purification using
the quick plasmid minipreps kit (Invitrogen). EcoRI digested
fragments were sequenced using universal forward T7 and reverse
M13 primers.
Sequence analysis and phylogenetic studies
For every selected clone, both forward and reverse amplified
nucleotide sequences were aligned using ‘‘Clustal X alignment’’
Figure 1. Geographic distribution of the studied population. Samples were collected systematically in the coloured areas without specific
focus on a particular site. Native inhabitants of these areas include a great variety of ethnicities among which are the Banen, Yebekolo and Soo in the
Centre (orange areas), the Bakola Pygmies, Mvae and Ngumba in purple colored area and finally the Baka Pygmies, the Bulu, Fang Badjoue and Zime
tribes located in the blue coloured areas. The 198 individuals from the ‘‘contact group’’ are indicated by red (SFV-infected) and yellow (SFV non-
infected) dots. The 2 SFV infected individuals from the ‘‘general population’’ are represented as black dots.
doi:10.1371/journal.ppat.1002306.g001
Recent Human Infection by Spumaviruses in Cameroun
PLoS Pathogens | www.plospathogens.org 3 October 2011 | Volume 7 | Issue 10 | e1002306software included in the DAMBE version 4.5.68 (Xia, X., Xie, Z.,
2001). Only one clone was considered when sequences were found
identical. A consensus sequence was built when one or more
nucleotides variations were found. A final consensus sequence was
built for every sample from its different clone’s consensus
sequences. Final sequences were aligned and compared to
different old world NHP prototype sequences. According to
Akaike Information Criterion (AIC), different evolutionary models
were tested using PAUP software version 4.0b10 (Sinauer
associates, Inc. Publishers, Sunderland, Massachussets). Phylogeny
was performed with the neighbour joining method and the best
tree was selected after a bootstrap analysis of 1000 replicates.
(Pro)viral loads
Quantitative PCR assays for DNA (qPCR) were performed
using the Eppendorf realplex master gradient detection system.
We used SYBR Green Quantitect (Qiagen) in a 20 ml volume
reaction containing 10 ml of SYBR Green buffer, 150 nM of each
primer and a 500 ng DNA sample. Five primer pairs were
designed in a region of the Integrase in the polymerase gene,
conserved among all our sequenced gorilla foamy virus strains.
Primers (GF5qpcr-TAGACCTGAAGGAACCAAAATAATTCC,
and GR5qpcr-TCCTTCCTCATATTAGGCCACC) gave the
best sensitivity (1 to 10 copies per 500 ng). They were designed to
detect a 144 pb nucleic acid region of the gorilla FV polymerase gene.
The optimized qPCR conditions used were as follows: 95uC for
15 min,40cyclesof:95uC for15 s,60uCfor30 s and 72uCfor30 s.
To standardize qCPR, a 465-pb region that included the PCR
target sequence from one primary isolate was cloned into a PCR
cloningvector,TOPO TA cloning kit (Invitrogen).Knownamounts
of thetarget gorillafoamy virussequence(from 1 to 10
4 copies)were
added to 500 ng of human genomic DNA from MS5 cell line
(fibroblastic cell line) to generate DNA standard curves. In addition
to a standard curve, each PCR run included a buffer-only and
foamy virus negative DNA controls. DNA derived from PBMC or
buffy-coat was used at 500 ng (75610
3 cell equivalents). A cellular
albumin qPCR was done on each sample to normalize with cellular
DNA content (albF-AAACTCATGGGAGCTGCTGGTT, albR-
GCTGTCATCTCTTGTGGGCTGT). Each DNA sample was
tested at least in duplicate. We checked in every individual assay the
specificity of the primers by using a melting curve.
Statistics
Statistical analyses were performed on Stata software. A
univariate analysis was performed for risk factors, by the double
entry Fisher exact method with a significance of p,0.05. A
multivariate analysis was performed to identify the most pertinent
factors associated to SFV infection.
Viral loads were compared across groups using Student t test
after logarithmic transformation. Categorical variables were
compared across groups using Chi-square and Fisher exact tests
where appropriate. Multivariable logistic regression was per-
formed to identify factors independently associated with SFV
infection.
Accession numbers
Bak50/JN049028, Bad179/JN049029, Bad202/JN049030,
Bad436/JN049031, Ako254/JN049032, Pyl149/JN049033,
Bad316/JN049034, Bad327/JN049035, Bobak153/JN049036,
Bobak237/JN049037, Lobak89/JN049038, Sabak36/JN049039,
Ako394/JN049040, Bak33/JN049041, Bak40/JN049042,
Bak55cl3/JN049043, Bak55cl2/JN049044, Lobak2/JN049045,
Bak46/JN049046, Bak56/JN049047, Bak74/JN049048, Bak82/
JN049049, Bak132/JN049050, Bak133/JN049051, Bak177/
JN049052, Bak224/JN049053, Bak228/JN049054, Bak232/
JN049055, Bak270/JN049056, Bad332/JN049057, Bad350/
JN049058, Bad348/JN049059, Bad349/JN049060, Bad447/
JN049061, Bad456/JN049062, Bad463/JN049063, Bad468/
JN049064, Bad551/JN049065.
Results
The population
A total of 1,321 individuals were included in the ‘‘general
population’’ group (table 1). There were 965 Bantus (males: 502,
females: 463) and 356 Pygmies (males: 179, females: 177). Ages
ranged from 5 to 90 years old in the Bantus and from 5 to 81 in the
Figure 2. Serological and molecular results patterns for SFV detection. A) Western blot results using purified classical chimpanzee antigen
sero-positive samples (lanes 3, 4, 6, 10, 12). Sero-indeterminate (lanes 2, 7, 8, 14). Sero-negative samples (lanes 5, 9, 11, 13). Positive SFV control serum
from a gorilla-infected human (lane 15), and a macaque (lane PC). B) Nested PCR detection of 465 bp Integrase sequences of SFV M=molecular
weight marker. CN=Negative Control. HFV=Human foamy virus, positive control, H2O=Water.
doi:10.1371/journal.ppat.1002306.g002
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51 years) than in the Pygmies (43 years), p,10
24.
In the ‘‘contact group’’, 198 persons, mostly males (males: 192,
females: 7), reported direct contact with a NHP and a resulting
wound (table 1). Pygmies in this group were older (24 to 75; mean
age=50 years) than Bantus (6 to 87; mean age=42 years),
p,10
24.
Encountered NHP species in the contact group
The different NHP species encountered by the hunters and
reported in the ‘‘contact group’’ are native to the study area and
are known to harbour specific SFVs [26,34,54]. Monkeys
encounters were reported as often (103/198; 52%) as those with
apes (95/198; 48%), (X
2=0.65, p=0.42). The most reported and
recognized small monkeys were Cercopithecus nictitans (41/103;
39.8%), C. cephus (36/103; 34.9%) and C. neglectus (16/103; 15.5%).
Baboons and mandrills (6/103, 5.8%) and other monkeys (4/103,
4%) were less frequently encountered. Among the apes, gorillas
were three times more prevalent (74/95; 77.9%) than chimpan-
zees (21/95: 22.1%), p,10
26. Double contacts with NHPs were
reported by only 3 individuals (2 Gorilla/Gorilla and 1
Chimpanzee/Monkey). Most of the individuals in the ‘‘contact
group’’ still had a noticeable scar or permanent physical injury
(figure 3).
Regarding ethnic distribution in the contact group, Bantus
(81.5%; 84/103) reported more contacts with small monkeys than
Pygmies (18.5%; 19/103) p,10
24. Chimpanzees and baboons
were equally often encountered in both ethnic groups, while
Pygmies (69%; 51/74) were more frequently in contact with
gorillas than Bantus (31%: 23/74), p,10
25 (table 2).
Overall, (83.3%) people aged up to 40 years are those most
frequently involved in hunting and subsequent contacts with
NHPs. Only (16.7%) were older, up to 70 years old, at the
moment of contact (figure 4-A). Most of the encounters with a
NHP (65.6%) had occurred within the last twenty years (range
from 1991 to 2001) (figure 4-B).
Serologic results
The WB results in the ‘‘general population’’ group, based on the
chimpanzee antigen revealed 2% (26/1,321) clearly positive
plasmas. Furthermore, 9.6% (127/1,321) of the tested samples
showed an indeterminate Gag profile (figure 2-A). The remaining
1168 samples showed no Gag reactivity and were considered
negative (table 1).
In the ‘‘contact group’’ WB analysis revealed 26.7% (53/198) of
positive plasmas. Indeterminate serology was found in 14.6% (29/
198) samples while the remaining 104 samples were clearly sero-
negative (table 1).
Molecular results
Buffy-coat DNA was available from all the individuals who
exhibited a positive or indeterminate WB in the ‘‘general
population’’ group (respectively 26 and 127) and in the ‘‘contact
group’’ (respectively 53 and 29), and was amplifiable using b-
globin specific primers.
Both pol-In and LTR PCRs were positive for two samples in the
‘‘general population’’ group (table 1, table 3). The 65 year-old
Bantu woman (Ako254) and 68 year-old Baka Pygmy man
(Bobak237) respectively reported frequent butchering activities of
wild games, including NHPs and the man reported frequent
hunting. None of them recalled known injury from a living NHP
during their lifetime.
In the ‘‘contact group’’, the nested PCR on the pol-In was
positive for 36 samples. The LTR PCR was positive for 37 samples
(table 3). Considering both PCRs, SFV DNA (pol-In or LTR) was
detected in 41 distinct individuals (table 1, table 3). SFV infection
prevalence is higher in this group as 18.6% (37/198) individuals
were ‘‘classically’’ infected whereas only 0.2% (2/1321) individuals
were found to be infected in the ‘‘general population’’ group
(X
2=256.7; p=,10
6). Apes (Gorilla, Chimpanzee) were involved
in 37 cases and small monkeys in only 2 cases (Table 3).
The considered classical definition of a SFV infection did not
apply to 4 samples in the ‘‘contact group’’ (table 4). Indeed, clear
positive results were obtained with both PCRs, but serology was
either negative (Bad179, Bad202) or indeterminate (Bad50,
Ako394). All four samples were tested in duplicate for the first
time and a second sample was collected, one (Bad50, Bad202) and
two years (Ako394) later. Individual Bad179 has been missing.
Their serological and molecular results profiles were unchanged.
Individual Ako394 encountered a gorilla 5 months before the first
sampling and reported a scratch on his left thigh. The three other
individuals encountered small monkeys during hunting activities.
Table 1. Global description of the general population group and the contact group, and overall serology and PCR results.
Ethnicity Sex Age range Mean age n Serology PCR
Pos N(%) Ind N(%) Neg Pos N(%) Neg
General pop Bantus M 5–88 51 502 4(0.8) 44(8.7) 454 0 48
F 6–90 463 8(1.7) 45(9.7) 410 1(0.2) 52
Pygmies M 5–80 43 179 10(5.6) 20(11.2) 149 1(0.5) 29
F 6–81 177 4(2.2) 18(10.2) 155 0 22
Total 1321 26(2) 127(9.6) 1168 2(0.2) 151
Contact group Bantus M 6–87 42 115 19(16.5) 17(14.8) 79 19(16.5) 17
F 28–75 5 0 1(20) 4 0 1
Pygmies M 24–75 50 76 34(44.7) 11(14.5) 33 22(29) 23
F 24–35 2 0 0 2 ND ND
Total 198 53(26.7) 29(14.6) 116 41(20.7) 41
Pop: population n: number of individuals in each group Pos: positive samples, Ind: Indeterminate samples, Neg: Negative samples PCR positive included positive
samples for pol-In and/or LTR.
doi:10.1371/journal.ppat.1002306.t001
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sampling (table 4).
Viral persistence
For 17 out of the 39 infected individuals in our series, we
obtained at least two different samples, after six months (Bak46,
Bad350, Bad447, Bad456), after one year (Bak33, Bak56, Bak74,
Bak82, Bak132, Bak133, Bobak153, Bak177, Bad348, Ako254),
after two years (Bad327) and after three years (Lobak2, Lobak89).
In all cases, we found identical serological and molecular positive
results. This findings associated to virus isolation in three cases
(Re ´jane Rua Personal data, not shown) demonstrate chronic viral
infection in these seventeen individuals harbouring SFV. In all 39
infected persons, viral persistence was estimated to range from 5
months to 45 years (mean=17 years), based on such findings and
the histories collected during field missions.
(Pro)viral loads
Viral loads were obtained for 33 samples from gorilla infected
individuals, using gorilla specific primers. The values, given per
10
5 cells, ranged from less than 1 to 145 copies, with a mean value
of 36 copies/10
5 cells. No difference in viral load was found
according to age at sampling (p=0.82), ethnicity (p=0.43), or
duration of infection (p=0.73) (Table 3, 4).
Figure 3. SFV infected individuals harboring scars and lesions caused by NHP bites. Scars from wounds by a small monkey in picture 1
(participant Bad50), chimpanzee in picture 2 (participant Bad327), gorilla in picture 3 (participant Bak56), picture 4 (participant Sabak36), picture 5
(Bad348), picture 6 (participant Bak132).
doi:10.1371/journal.ppat.1002306.g003
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Monkey species N(%) Apes N(%)
C. nictitans C. cephus Others Chimpanzee Gorilla
Risk population Bantus 36 29 19 12 23
Pygmies 5 7 7 9 51
41(39.8) 36(34.9) 26(25.2) 21(22.1) 74(77.9)
Description of the NHP species was done by the concerned individuals themselves and a record was made on the written questionnaire. Visuals were showed to help
them precisely identify the animal. Others=C. neglectus, Papio, Colobus, cercocebus, Mandrills.
doi:10.1371/journal.ppat.1002306.t002
Figure 4. Distribution of tested and infected individuals from the ‘‘contact group’’. A) According to the age at contact with NHP
B) According to the time of the contact with NHP.
doi:10.1371/journal.ppat.1002306.g004
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PLoS Pathogens | www.plospathogens.org 7 October 2011 | Volume 7 | Issue 10 | e1002306Table 3. Epidemiological and ‘‘classical’’ biological features of SFV infected humans in contact group and general population.
Groups Ethnicity Samp/sex
Age at:
cont/samp
Samp
periods
Wound loc/
severity Serology
PCR pol-In/
LTR Origin
(Pro)viral
LoadW
Contact Group Pygmies Pyl149/M 45/60 2008 Hand/2 ++ /+ Cpz ND
Bobak153/Me{ 53/59 2006/09 Hand/2 ++ /+ Gor 20
Mebak65/MD 20/40 2006 Body/2 + 2/+ GorY ,1
Lobak2/Me{ 37/57 2006/09 Thigh/3 ++ /+ Gor 32
Lobak89/Me{ 20/50 2006/09 Arm/2 ++ /+ Gor ,1
Sabak36/M 40/68 2006 Forearm/3 ++ /2 Gor 63
Bak33/Me{ 25/45 2008/09 Multiple/3 ++ /+ Gor 24
Bak40/M 30/35 2008 Thigh/2 ++ /2 Gor 14
Bak46/Me{ 26/50 2008/08 Multiple/3 ++ /+ Gor 76
Bak55/M{ 30/65 2008 Arm/2 ++ /+ Gor 145
Bak56/M{e 40/65 2008/09 Hand/2 ++ /2 Gor 57
Bak74/M{e 26/47 2008/09 Foot/2 ++ /+ Gor 117
Bak82/M{e 46/50 2008/09 Leg/2 ++ /+ Gor 36
Bak132/Me 30/61 2009/10 Head/3 ++ /+ Gor 27
Bak133/M{e 30/51 2009/10 Several/3 ++ /+ Gor 2
Bak177/M{e 26/36 2009/10 Leg/3 ++ /+ Gor 122
Bak188/MD 15/48 2009 Hand/1 + 2/+ CercoY ND
Bak224/M{ 19/38 2010 Several/3 ++ /+ Gor 28
Bak228/M{ 29/70 2010 Foot/3 ++ /+ Gor 34
Bak232/M{ 40/60 2010 Hand/2 ++ /+ Gor 59
Bak235/M{D 27/55 2010 Hand/2 + 2/+ GorY ,1
Bak242/M{ 30/49 2010 Leg/2 ++ /+ Gor 26
Bak270/M 25/60 2010 Hand/2 ++ /+ Gor ,1
Bantus Camvae3/MD 25/29 2008 Foot/2 + 2/+ CercoY ND
Bad316/M{ 36/51 2008 Hand/2 ++ /+ Cpz ND
Bad327/M{e 30/33 2008/10 Multiple/3 ++ /+ Cpz ND
Bad332/M{ 25/37 2008 Multiple/3 ++ /+ Gor 31
Bad348/M{e 19/27 2008/09 Leg/3 ++ /+ Gor 8
Bad349/M{ 32/40 2008 Head/2 ++ /+ Gor 41
Bad350/Me 40/68 2008/08 Leg/2 ++ /+ Gor 22
Bad436/M{ 35/56 2009 Hand/2 ++ /+ Cerco ND
Bad447/Me{ 40/56 2009/10 Hand/2 ++ /2 Gor 9
Bad448/M{D 44/50 2009 Leg/2 + 2/+ GorY ,1
Bad456/Me{ 24/30 2009/10 Leg/2 ++ /+ Gor 23
Bad463/M{ 37/43 2009 Leg/3 ++ /+ Gor 72
Bad468.M{ 23/35 2010 Several/3 ++ /+ Gor 26
Bad551/M 27/38 2010 Arm/2 ++ /+ Gor ,1
General pop Pygmy Bobak237/M 2/68 2006 Unknown ++ /+ Gor 57
Bantu Ako254/F{e 2/65 2008/09 Unknown ++ /+ Cerco ND
Pop: population. Loc: location. Cont: contact. Samp: sampling. SFV: Simian Foamy Virus. LTR: Long Terminal Repeat. Gor: Gorilla. Cpz: Chimpanzee. Cerco: Cercopithecus/
Ind: Indeterminate/ +: Positive/ 2: Negative/ ND: Not determined for Chimpanzees and small monkeys infected individuals. Wound severity: 1=low, 2=medium,
3=high.
e: sampled twice and tested two times for serology and PCR/.
{: family members also tested (spouse and/or children).
D: LTR was sequenced and blasted. In all cases, correspondence was found with the history.
W: (pro)viral loads are reported per 10
5 cells.
Y: No Integrase sequence obtained.
doi:10.1371/journal.ppat.1002306.t003
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Thirty-eight sequences of the 425 bp fragment of the polymer-
ase gene were obtained from PCR amplicons (GenBank accession
numbers JN049028 to JN049065).
Comparative analysis of these new sequences with prototypic
strains of African Apes and small monkeys indicates that 30 strains
were of gorilla origin (Gorilla gorilla gorilla), and 3 from a
chimpanzee of the Pan troglodytes troglodytes susbspecies, the only
type living in these areas. The 5 remaining sequences were from
small monkeys, mostly from the Cercopithecus sp. A perfect match
was found between the histories collected in the ‘‘contact group’’
and the obtained sequences. Only one gorilla sequence was found
in individual Bak133 and Bad 468 who were both bitten twice by a
different gorilla at different periods. Participant Bad436, who
reported a bite by a chimpanzee and one by a small monkey, was
found to be infected by a Cercopithecus virus. Lastly, two different
gorilla sequences (Bak55cl2, Bak55cl3) were amplified from 55
year-old participant Bak55 whose field interviews reported only
one remembered gorilla bite but he had been frequently hunting
and butchering NHPs throughout his life.
Translation of manually purified sequences resulted in amino
acid sequences without stop codons. Pairwise alignments showed a
higherpercentageofsimilaritybetween sequencesinsideeachgroup
and indicated a higher variability among monkey SFVs. Polymor-
phism analysis among the Cercopithecus SFV strains indicated
respectively nucleotides and amino acids similarities of 82.1% to
99% and 64.7% to 97.7%. Sequences of the chimpanzees were also
all unique and nucleotide similarity ranged from 96% to 99% while
it was 91.7% to 99% for amino acids. Concerning the 30 strains of
gorillaorigin,comparativeanalysisindicatesthatwhilemost(25/30)
of them differed from each other by some polymorphisms (ranging
from 0.3% to 6.4% for nucleotides and 0.8% to 14.3% for amino
acids), a few others where identical. Indeed, sequences from
Lobak2, Bak46, and Bak56 showed 100% nucleotide identity.
Bak46 and Bak56 lived almost 20 km from each other at the time of
sampling, while Lobak2 was 130 km and 160 km respectively from
the others. Bad348 and Bad349 are two Bantu individuals from the
same village who exhibited an identical gorilla sequence. They were
bitten both on the same day by the same gorilla. Lastly, a sequence
from Bobak153 was identical to a sequence (Cam1083) obtained in
an infected hunter, in a previous study performed in a rural village
in the low land forest of southern Cameroon [46]. The indicated
sampling site (area IX) was around 180 km away from the home of
Bobak153, which is also the area where the encounter with the
gorilla occurred.
Since tree-building algorithms rely on different assumptions, we
used two different methods, neighbour-joining (NJ) and maximum
likelihood to increase reliability of the derived tree topologies. A
first comprehensive study was done with NJ and 1000 bootstrap
values, using the 33 new obtained pol-In sequences from apes and
a selection of prototypic sequences, available in Genbank, from
chimpanzees and gorilla. We also included in this study, FV strains
from persons infected by African apes. As seen in Figure 5, the
different established main clades were identified on the basis of
consistent topology and high bootstrap values. Indeed, a first large
clade comprised all the strains of gorilla origin, including especially
the 30 new ones obtained in our study. A second large clade
comprises sequences from all the different chimpanzee subspecies.
Clearly, the three chimpanzee strains identified in the current
study clustered with the Pan troglodytes troglodytes subpecies group
strains. A similar tree topology was found using the maximum
likelihood method (data not shown). Concerning the small monkey
FV sequences, a phylogenetic analysis performed with most of the
FVs from African monkeys clearly indicates that the 5 new
sequences originated from Cercopithecus sp. They cluster into two
different subgroups supported by high bootstrap values. A first
particular subgroup is supported by a 99% bootstrap value and
includes 4 new sequences which represent four newly documented
human infections by a Cercopithecus neglectus (De Brazza guenon)
SFV. The other sequence (Ako254) clusters within the Cercopithecus
nictitans subgroup, supported by a 94% bootstrap (figure 6).
Analysis of associated factors
Epidemiological analysis of associated factors for SFV infection
in this area was performed on all 1,519 individuals in our series.
The univariate analysis of factors associated with SFV infection
showed a highly significant association with male sex (p,10
24,
x
2=24.6), with the Pygmies (p,10
24, x
2=20.85), hunting
(p,10
24, x
2=233.5), apes (p,10
24, x
2=446.2), bites (p,10
24,
x
2=267.1) and wounds to the upper part of the body. No
significant association was reported for age at contact (table 5). A
multivariate model was applied to these combined factors in which
only apes (p,10
24) and bites (p=0.005) were independently
associated with SFV infection in this series.
Secondary intra-familial transmission
A secondary intra-familial transmission was searched for in 12
children aged 9 to 37 years born after the presumed infecting
contact and in 30 wives aged 23 to 65 years and who had lived
from 1 to more than 30 years with the index case after the
Table 4. Epidemiological and ‘‘non-classical’’ biological features of SFV infected humans in contact group.
Groups Ethnicity Samp/sex
Age at:
cont/samp
Samp
periods
Wound loc/
severity Serology
PCR pol-In/
LTR Origin
(Pro)viral
LoadW
Contact Group Bantus Ako394/M*e{ 53/53 2008/10 Thigh/1 Ind +/+ Gor 8
Bad50/M* 56/60 2008/09 Arm/2 Ind +/+ Cerco ND
Bad179/M* 44/46 2008 Leg/2 2 +/+ Cerco ND
Bad202/M*e 30/31 2008/09 Leg/2 2 +/+ Cerco ND
Loc: location. Cont: contact. Samp: sampling. SFV: Simian Foamy Virus/ LTR: Long Terminal Repeat/ Gor: Gorilla/ Cerco: Cercopithecus/ Ind: Indeterminate/ +: Positive/ 2:
Negative/ Wound severity: 1=low, 2=medium, 3=high.
*: were serologically tested at least twice with Chimpanzee’s antigen. Result profile was invariable. Western Blot with small monkey’s (Cercopithecus) antigen was
positive for Bad50 and invariably the same for the three others.
e: sampled twice and tested two times in serology and PCR/.
{: family members also tested (spouse and/or children).
W: (pro)viral loads are reported per 10
5 cells.
doi:10.1371/journal.ppat.1002306.t004
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PLoS Pathogens | www.plospathogens.org 9 October 2011 | Volume 7 | Issue 10 | e1002306Figure 5. Rooted phylogenetic tree generated with consensus sequences of 425 bp fragments of the SFV pol-In from apes-infected
hunters and prototype old world non-human primates from the apes’ clades. The final consensus sequences from our study are
highlighted in red (gorilla) and green (chimpanzee). Sequences are compared to known prototypes from different central African NHP species.
Alignment was performed with Dambe version 4.5.68 and Clustal W. Phylogenetic analysis was performed with Paup, version 4.0b10 (Sinauer
Associates, Sunderland, MA, USA) based on the Neighbour joining method applying the GTR model. Bootstrap analysis of 1000 replicates is indicated
as numbers at nodes. Only values greater than 60% are shown. The scale of the tree is 0,1 nucleotide replacements per site. The tree is rooted on a
divergent sequence from an Asian macaque. Species found in Cameroon are shown with asterisks. Sequences accession numbers are: JN049036 to
JN049065 for gorilla sequences and JN049033 to JN049035 for Chimpanzee sequences.
doi:10.1371/journal.ppat.1002306.g005
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tested serologically. Among the women, only a 51 year-old woman
Bad460 (married to Bad447) was clearly sero-positive, while three
others, wives of Bobak153, Bak46 and Bak55, were sero-
indeterminate. Among the children, a nine year old male child
Bak108 (son of Bak40) was sero-indeterminate. Repeated PCR
analyses on samples from these five individuals were negative for
the pol-In and for the LTR. A second sample was collected 6
months later and still showed similar results.
Discussion
This study reports the largest series yet published, of humans
infected with a simian foamy virus, a retrovirus highly endemic in
NHPs. Furthermore, this work provides the first data, to our
knowledge, concerning the peripheral blood viral load of such
retroviral and zoonotic infection in human, by a quantitative PCR
method. We report also the negative search for this viral infection
in a large series of spouses and children from infected index cases.
Lastly, this study reinforces the findings that such zoonotic
infection is mainly but interestingly not exclusively acquired
through contacts occurring during bites by NHPs. These
observations bring out a greater concern on questions concerning
the natural history of SFVs in humans:
1) What is the magnitude of such human infection in
areas highly endemic for infected NHPs, especially in
Central Africa?
Concerning central Africa, the work pioneered by Wolfe et al
[46], which was followed by our preliminary study [47] identified
16 persons infected by SFVs, as demonstrated by both serological
Figure 6. Rooted phylogenetic tree generated with consensus sequences of 425 bp fragments of the SFV pol-In from monkeys-
infected hunters and prototype old world non-human primates from the small monkeys’ clades. The final consensus sequences from
our study are highlighted in blue (monkeys). Sequences are compared to known prototypes from different central African NHP species. Alignment
was performed with the Dambe version 4.5.68 and Clustal W. Phylogenetic analysis was performed with Paup, version 4.0b10 (Sinauer Associates,
Sunderland, MA, USA) based on the Neighbour joining method applying the GTR model. Bootstrap analysis of 1000 replicates is shown as numbers at
nodes. Only values greater than 60% are shown. The scale of the tree is 0,1 nucleotides replacement per site. The tree is rooted on a divergent
sequence from an Asian macaque. Species found in Cameroon are shown with asterisks. Sequences accession numbers are: JN049028 to JN049032.
doi:10.1371/journal.ppat.1002306.g006
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persons infected by SFVs of NHP origin. Taken together, these
data demonstrate FV infection by a wide diversity of NHPs
species, in individuals living in different geographical areas of
South Cameroon and originating from different ethnic groups
(several Bantu groups and two tribes of Pygmies). As only a small
proportion of the inhabitants of this large region has been tested
for such viruses, it is, however, possible to estimate conservatively
that, at least, several hundreds of adults are infected by SFVs in
southern Cameroon [55]. The situation is barely known for other
African countries. Indeed, apart from one case of infection in a
commercial sex worker (CSW) in the Democratic Republic of
Congo (DRC)/ex Zaire) [56], only two recent preliminary reports
from ongoing studies, indicate the presence of similar zoonotic
infection in Gabon (Mouinga-Ondeme, 2011, Abstract Retrovi-
rology) and the DRC (Switzer, 2011, Abstract Retrovirology).
Interestingly, in Central Africa, the number of contacts between
humans (mostly hunters and their wives and butchers) and NHPs
has very probably greatly increased during the last decades [57].
This is mainly due to increased hunting activities, which results
from a combination of urban demand for bush-meat, greater
access to NHP habitats provided in part by logging roads, easier
accessibility to fire arms, and finally, an increase in populations
living in forest areas, and the associated increase in local food
needs [58]. The results of our study fully support the role played
by such factors. Indeed, most (83%) of the SFV infected
individuals were relatively young hunters (up to 40 years old)
when the presumed infecting contact occurred, but more
surprisingly, 16.7% of these contacts occurred within the last 20
years (1991 to 2011). This clearly indicates that hunting NHPs is
still an ongoing activity in villages and settlements of southern
Cameroon, especially around areas rich in game, such as nature
reserves (figure 1). Such hunting activities represent a high-risk
occupation for a wide diversity of retroviral zoonotic infections
including not only SFVs, but also other retroviral infections such
as SIV [16,17,59,60] and STLV [11,12,61]. Indeed, even if most
of the 16 cumulative cases of human SFV infection reported
previously from Cameroon [46,47] and most of our current 39
cases, were infected by a FV from gorilla (69%, 38/55), at least
seven other species of NHPs can also lead to a SFV zoonotic
infection in humans. These include chimpanzee, mandrill, baboon
and also the most frequently hunted game, including cercopithecus
nictitans, cercopithecus cephus, cercopithecus neglectus and some colobus and
cercocebus.
Another point concerning the estimation of the prevalence of
SFV infection in human relates to the quite frequent finding of a
positive WB serology associated with a negative detection of SFV
(in the blood cells) by PCR. Such was the case for 32% (17/53) of
WB positive individuals in the ‘‘contact group’’ and 80.7% (21/26)
of WB positive persons in the ‘‘general population’’ (data not
shown). Whether these persons are infected or not remains
unclear. They were not considered as infected in the present study.
Similar findings have already been reported and discussed in the
literature [46,47] and might be related to low viral loads in the
blood or less likely, to the presence of divergent SFV strains, not
recognized by the generic primers used. These primers can detect
and amplify a large variety of African SFVs, and also Asian
macaque strains [26,29,32,54]. Non-specific reactivity with the
SFV Gag proteins (or Gag-only responses) can also be considered
as a cause for these profiles.
In this work, we have reported 2 individuals being either sero-
indeterminate (only one band by WB) or even sero-negative (2
cases) but in whom we confirmed presence of SFV DNA in their
leucocytes blood. Such findings may be related to several factors
including a possible long delay of sero-conversion in some cases,
especially the individual having been bitten only few months
before the sampling. Another possibility could be an individual
lack of sero-reactivity for certain proteins as it has been well
described in several HTLV-1 or STLV-1 infection, especially for
the p24 or some env proteins or peptide [62,63]. Lastly, in the few
persons infected by a Cercopithecus monkey foamy strain, this could
be linked to the fact that we have used in our WB chimpanzee
viral antigens. However, such antigens cross-react strongly to most
of the African and Asian SFV yet tested as demonstrated in several
published studies [29,32,46,47].
2) Is SFV infection pathogenic in humans?
The potential for an SFV infection to cause disease in humans is
not yet fully understood. The apparent lack of pathogenicity in
infected persons, which is still based on a very limited number of
cases [45,64], contrasts strongly with the massive in-vitro lytic
properties of these FVs in monkey and human cells [65].
Furthermore, the selection bias inherent in the enrolment of
healthy persons in our study, as well as in all of the few published
investigations greatly limits the ability to identity any severe acute
Table 5. Factors associated to SFV infection in studied
populations.
Risk factors Number of individuals p
Tested Positive %
Age at contact
,50years 783 19 2.43
.50years 736 18 2.45 0.98
Sex
Woman 647 1 0.15
Man 872 36 4.13 ,10
23
Ethnicity
Bantus 1084 14 1.29
Pygmies 412 23 5.29 ,10
23
Circumstances of contact
Hunting 190 35 18.42 ,10
25
Pets 8 0 0
No contacts 1321 2 0.15
Type of NHP
Monkeys 103 2 1.94 ,10
25
Apes 95 33 34.74
No contacts 1321 2 0.15
Type of contact
Bites 187 31 16.5 ,10
25
Scratches 6 1 16.6
Both 5 3 60
No contacts 1321 2 0.15
Localisation of the Wound*
Upper body 114 21 18.3
Lower body 68 14 20.59 ,10
23
No contacts 1332 2 0.15
Univariate analysis was performed with stata. x
2 and fisher exact test were
realised with a critical p value of 0.05.
*missing data in this category (5).
doi:10.1371/journal.ppat.1002306.t005
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infected persons reported here, is ongoing to try to detect any
potential clinical chronic disease and/or biological abnormalities
in persons chronically infected with SFV. However, we have also
to keep in mind that the incidence of a disease in a person
chronically infected by a retrovirus might be very low and may
follow a very long latency. Such features are well exemplified by
HTLV-1 infection, another human primate retrovirus of zoonotic
origin [66]. Another important issue concerns the possible co-
infection by SFV and HIV in the same individual. This has been
reported by Switzer et al., in two persons (one CSW and one blood
donor) from DRC and Cameroon respectively [56]. Due to the
HIV pandemic, in areas where SFV infected persons live (Central
Africa and South-East Asia), such co-infections are surely greatly
underestimated. Whether HIV-induced immunosuppression could
increase the likelihood of developing a disease due to SFV
infection remains unknown [55,56,67]. Interestingly, cellular
tropism of SFV was shown to be enhanced in SIV-induced
immunosuppression in a macaque model [37].
3) How are SFVs transmitted from apes and monkeys to
humans?
As seen above, most (37/39=95%) of the persons infected by a
SFV had been bitten, often severely, with persisting scars, by a
NHP. These data are consistent with our preliminary study in
another area of Cameroon, with a severe bite reported in 12/13
infected persons [47]. Similarly, 6 of 8 SFV infected persons in
Southeast-Asia reported having been bitten by a macaque, at least
once [48]. Furthermore, in persons occupationally exposed to
NHPs in primate centres, zoos and laboratories in Germany and
North America, the majority of the infected individuals reported
also a bite from a NHP [41,44,68]. This situation is also
exemplified by a recently published study performed in the
CIRMF in Gabon [31]. The high rate of infection by gorilla and
chimpanzee FVs in our study (17%, 34/198) as compared to other
monkeys (1.5%, 3/198), may be related to the severity of the
wounds during apes bites. Indeed, in such cases, tissue damage is
much more serious (with soft tissue crushing, tearing and bleeding)
with possibly deeper and longer contact between apes saliva and
blood of the human hunter. In infected monkeys, especially in
macaques, studies have provided evidence that SFV is present
at high concentrations in saliva and oral mucosa, with viral
replication [36,37,38]. Furthermore, it appears that in a semi-free
colony of macaques, SFV is mostly acquired through severe bites
usually in young adults when they compete for sexual partners
[32]. A paper also strongly suggests that chimpanzees acquire SFV
by horizontal routes, most likely by exposure to saliva [69].
Therefore, all these data indicate that blood and/or injured tissue
contact with saliva are the key factor for this form of zoonotic
transmission.
No infection was found in the 8 individuals bitten by pets in our
study despite 2 WB indeterminate results (data not shown). Pets
are usually small sized orphan monkeys, captured at young age,
free of infection and brought in the villages where they are raised,
away from contacts with infected adult monkeys. Moreover, bites
when they happen are almost always superficial.
However, grooming as shown in SFV-infected felines, and
possibly to a lesser extent sexual contacts, may also lead to
transmission between NHPs [23]. It is thus noteworthy that in our
study, as in most of the few other studies reporting SFV infection
in humans, some of the infected individuals had not reported
severe injuries or bite from a NHP [44,45,47,48]. Furthermore, in
some cases, the species that inflicted the injury was not the same as
that associated with the infecting SFV strain [45]. Indeed, to our
knowledge, a dozen of cases have been reported world-wide
among the currently known 85 SFV infected persons, including
the 39 from our study. This may suggest that, in some cases,
infection occurs through other routes than bites, including from
saliva spraying into small open wounds or unprotected muco-
cutaneous areas without clear injury. Such a possibility can
therefore not be ruled out in the only SFV infected case associated
with gorilla scratches in our study (Ako394 table 4). Considering
that a majority of people living in West Central Africa frequently
butcher, cut or manipulate NHP carcasses or meat [57,58], other
modes of contamination involving external mucosal contacts with
infected saliva may be considered. This mode of transmission is
likely in this study for the two infected cases in the ‘‘general
population’’ series who did not report a NHP bite during their
lifetime (Bobak237, Ako254 in table 3). Some transmission routes
may be similar to that of transmission for simian herpes B [70]. A
better knowledge of such risk factors is important to establish
proper protective equipment that should be recommended for
worker safety in zoos and primate centres.
4) Are these simian viruses transmissible from human to
human?
Person to person transmissibility of zoonotic SFV infection
remains unclear at present. A major concern of our study was the
search for secondary intra-familial transmission from index cases
to their close relatives. Indeed, to our knowledge, only 11 spouses
of SFV infected persons (6 from workers in North America [45]
and 5 in our previous study in Cameroon [47]) and very few of
their children that have been tested. They were all found negative
for SFV infection.
In our current series, one woman was interestingly found
repeatedly (two times at 6 months interval) to be SFV seropositive
among the 30 tested wives of SFV infected hunters. This 51 year-
old woman had lived for 6 years with index case Bad447, after
probable infectious contact and they had not had children. In the
absence of a positive PCR with a sequenced SFV DNA fragment
comparable to that of her husband, we can not formally rule out, a
serological reaction secondary to circumstantial exposition to a
virus from the husband. This probably coincidental sero-reactivity
could be, as said before, either a non specific Gag reactivity, or a
low viral load SFV infection acquired through another route.
Besides, the infection may probably not be transmitted given the
quite low (pro)viral load (9 copies for 10
5 cells) observed in the
husband (Bad447) (Table 3).
These data indicate that SFV transmission from man to woman
does not occur easily by sexual contact or saliva exposure, as
previously suggested in the literature [41,44,45,47].
Disease occurrence and transmissibility are related to in-vivo
(pro)viral load levels in an infected person. We provide here, to our
knowledge, the first data concerning the level of (pro)viral load, as
determined by a quantitative PCR method, in persons chronically
infected by SFV of zoonotic origin. Our results, based on a series
of 28 individuals, all infected by a gorilla virus, indicate a low viral
load (in the DNA of the peripheral blood cells) of most persons, but
with a quite large range (,1 to 145 copies per 10
5 cells). The
degree of this viral load may be related to the origin of the virus
(apes versus small monkeys for example) but also to genetic factors,
including innate restriction, as already shown for other human
retroviral infection of zoonotic origin such as HIV-1 and HTLV-1
[71,72,73].
In our series, we have found a women (Ako254) infected by a
SFV from a Cercopithecus. This is, to our knowledge, the fifth
reported case of an infection by a SFV in a woman (as
demonstrated by both serological and molecular means)
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Southeast Asia and sero-positive for macaque SFV have been
reported, without demonstration of viral DNA presence in their
blood [48]. All together, these data indicate, as already suggested
[44], that SFV might also be spread from mother to child and/or
through sexual contacts with infected women.
The demonstration of highly frequent and recent SFV infections
by this study raises important public health concerns not only
about the risk for the acquisition of SFV, but also about the
consequences of such a zoonosis with regard to other simian
viruses that may cause disease in humans [4,58,67,74]. This
emphasizes the need for continued long term monitoring of SFV
infected individuals to evaluate any changes in host and viral
dynamics. Although evidence of a secondary transmission are still
sought, vigilance must be maintained on the possible emergence of
human-to-human transmission from infected individuals, since
SFV transmission by blood transfusion has been demonstrated in a
monkey model [42,75] demonstrating infected blood as a mode of
virus transmission. Dual infections with SFV and HIV-1 have
been reported [56], and the outcome of such an infection in an
immunosuppressed person is unknown. Strategies for proactive
preparedness for SFV strains that may have the potential for
human transmission and clinical outcome must be implemented.
Efforts to reduce the risk of cross-species infection are necessary to
control the potential threat of new simian pathogens, such as
SFVs. Therefore, general public education would be necessary in
these areas where interaction with NHP, mostly through hunting is
part of culture and tradition, as well as related to economic needs.
Preventive actions must then be taken, considering supply
alternatives to hunting.
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